Artificial Intelligence (AI) in Biotechnology Market Size, Share, By Offering (Hardware, and Software & Services), By Application (Health Informatics, Therapeutic Development, Epidemiological Modeling, Remote monitoring & Wearable, and Others), By Usage (Forensic Biotechnology, Clinical Biotechnology, Environmental Monitoring, and Others), and Region - Trends, Analysis and Forecast till 2034

Predicting possible medication candidates and cutting down on preclinical testing time are two ways AI is speeding up the drug discovery process. Large pharmaceutical corporations are collaborating with artificial intelligence firms to improve the efficacy of medicinal chemical identification. As AI technologies like deep learning and neural networks continue to advance, this approach is becoming more and more popular.

With its ability to analyze massive patient genomes, proteome, and metabolomics datasets, AI is significantly contributing to the advancement of precision medicine. AI-driven algorithms improve outcomes in areas like cancer therapy and uncommon diseases by developing personalized treatment strategies based on genetic makeup.